Christopher Richard Anzalone, CEO: Arrowhead Pharmaceuticals ARWR Sell · Filed 25/12/30

Trade details

Type: Insider sale
Amount: $2,439,098.73
Shares · price: 35,181 sh · $69.33 a share
Held after: 3,822,471 sh
Stock: Arrowhead Pharmaceuticals ARWR
Person: Christopher Richard AnzaloneCEO
Trade date: 25/12/29
Filed: 25/12/30
Days to filing: 1 days

Sold 0.9% of holdings

Share of holding sold: 0.9%

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/11/29~01/28

Christopher Richard Anzalone's recent trades

Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$488.6K
7,416 sh
$488.6K
Filed 01/05
Traded 01/02
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$383.1K
5,771 sh
$383.1K
Filed 01/05
Traded 01/02
Christopher Richard AnzaloneCEO
Planned sale10b5-1 planArrowhead Pharmaceuticals
Planned sale10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$871.7K
13,187 sh
$871.7K
Filed 01/02
Traded 01/02
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$1.1M
16,545 sh
$1.1M
Filed 25/12/30
Traded 25/12/29
Christopher Richard AnzaloneCEO
Planned sale10b5-1 planArrowhead Pharmaceuticals
Planned sale10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$3.6M
51,726 sh
$3.6M
Filed 25/12/29
Traded 25/12/29

Christopher Richard Anzalone, CEO — sold $2.4M of Arrowhead Pharmaceuticals ARWR · 0.9% of holdings · 10b5-1 plan | Whalegun